+0.04
+0.30%
| Symbol | Value ($) |
|---|---|
| Morningstar Rating | |
| Previous Close | 13.14 |
| Category | Foreign Large Growth |
| Net Assets | 5.26 Bil |
| Yield | 1.43% |
| Morningstar Risk | Average |
| Morningstar Return | High |
- Last NAV update 5/17/2013 3:00 AM ET
| NA |
|---|
| The investment seeks capital appreciation. The fund normally invests primarily in non-U.S. securities, including securities of issuers located in emerging markets. It normally invests primarily in common stocks. The fund normally invests in companies Fidelity Management & Research Company believes have above-average growth potential. It allocates investments across countries and regions. The fund uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions to select investments. |
| 2009 | 2010 | 2011 | 2012 | 2013 | |
|---|---|---|---|---|---|
| Return | NA | 16.44% | -9.38% | 19.49% | 10.85% |
| Value ($) | NA | 11,644.00 | 10,551.79 | 12,608.33 | 13,976.33 |
- Year to date performance as of 5/16/2013 8:00 PM ET
| Symbol | Value ($) |
|---|---|
| Fund Family | Fidelity Investments |
| Fund Manager | Jed Weiss |
| Tenure (Years) | 3 |
| Fund Status | Open |
| Minimum Initial Purchase | 0.00 |
| Minimum IRA Investment | NA |
| Front Load | 0.00 |
| Expense Ratio | 1.04% |
| Symbol | Value ($) |
|---|---|
| 1 Month | 5.69% |
| 3 Months | 6.20% |
| 1 Year | 28.27% |
| 3 Years* | 14.41% |
| 5 Years* | NA |
- * Annualized returns
- Performance as of 5/16/2013 8:00 PM ET
| FIGSX | Foreign Large Growth | |
|---|---|---|
| 5-Yr Return | NA | 0.03% |
| Sharpe Ratio | 0.67 | 0.50 |
| Net Assets | 5.26 Bil | 616.01 Mil |
| Avg Market Cap | 28.72 Bil | 25.37 Bil |
| Avg P/E | 17.53 | 14.92 |
| Portfolio Turnover | 27 | 45 |
| Symbol | Value ($) |
|---|---|
| Stocks | 95.78% |
| Cash | 4.21% |
| Fixed Income | 0.00% |
| Other | 0.01% |
| NAME | % NET ASSETS |
|---|---|
| Nestle SA | 5.11% |
| Anheuser-Busch Inbev SA | 3.63% |
| Roche Holding AG | 2.39% |
| Novo Nordisk A/S ADR | 2.37% |
| Linde AG | 2.34% |
| GlaxoSmithKline PLC ADR | 2.24% |
| Standard Chartered PLC | 2.12% |
| SABMiller PLC | 2.02% |
| Denso Corporation | 2.00% |
| CSL Limited | 1.99% |
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
